Sulzer Medica USA Holding Co. – ‘3’ for 12/27/00 re: Capital Partners II Ltd. Liquidating Trust

As of:  Friday, 1/5/01   ·   For:  12/27/00   ·   Accession #:  929624-1-5   ·   File #:  0-32003

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of           3     14K 
                Securities by an Insider                                         

3
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
+--------+                                                                      
| FORM 3 |          U.S. SECURITIES AND EXCHANGE COMMISSION                     
+--------+                  WASHINGTON, D.C. 20549                              

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, 
Section 17(a) of the Public Utility Holding Company Act of 1935 or  
Section 30(f) of the Investment Company Act of 1940 

--------------------------------------------------------------------------------
1.  Name and Address of Reporting Person                                        

Sulzer Medica USA Holding Co.                                           
    ----------------------------------------------------------------------------
   (Last)                      (First)                        (Middle)

3 East Greenway Plaza, Suite 1600                                     
    ----------------------------------------------------------------------------
(Street)  

  Houston,                      Texas                            77046
    ----------------------------------------------------------------------------
   (City)                      (State)                           (Zip)

2.  Date of Event Requiring Statement (Month/Day/Year)               12/27/00   
                                                                  --------------

3.  IRS or Social Security Number of Reporting Person (Voluntary)               
                                                                  --------------

4.  Issuer Name and Ticker or Trading Symbol  Capital Partners II Ltd.          
                                            ------------------------------------
Liquidating Trust                                                       
    ----------------------------------------------------------------------------

5.  Relationship of Reporting Person to Issuer (Check all applicable)           

[ ] Director    [ ] Officer             [X] 10% Owner    [ ] Other      
                        (give title below)                       (specify below)

    ----------------------------------------------------------------------------

6.  If Amendment, Date of Original (Month/Day/Year)                             
                                                    ----------------------------

7.  Individual or Joint/Group Filing (check Applicable Line)                    

Form filed by One Reporting Person                                
---                                                                       

X  Form filed by More than One Reporting Person                         
---                                                                       

TABLE 1--NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED 

                                                                [Download Table]

--------------------------------------------------------------------------------
1. Title           2. Amount of         3. Ownership Form:  4. Nature of        
   of                 Securities Bene-     Direct (D) or       Indirect Bene-   
   Security           ficially Owned       Indirect (I)        ficial Ownership 
   (Instr. 4)         (Instr. 4)           (Instr. 5)          (Instr. 5)       
--------------------------------------------------------------------------------
                                                                                

--------------------------------------------------------------------------------
   Trust Units        21,627               (D)                                  
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

*If the Form is filed by more than one Reporting Person, see Instruction        
5(b)(v).                                                                        
Reminder: Report on a separate line for each class of securities beneficially   
owned directly or indirectly.                                                   

3
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
                                                        [Enlarge/Download Table]

------------------------------------------------------------------------------------------------------------------------------------
 1. Title of Derivative        2. Date Exer-    3. Title and Amount of Securities   4. Conversion   5. Ownership   6. Nature of In- 
    Security (Instr. 4)           cisable and      Underlying Derivative Security      or              Form of        direct Bene-  
                                  Expiration       (Instr. 4)                          Exercise        Derivative     ficial        
                                  Date                                                 Price           Security:      Ownership     
                                  (Month/Day/                                          of              Direct (D)     (Instr. 5)    
                                  Year)                                                Derivative      or In-                       
                              ----------------------------------------------------     Security        direct (I)                   
                               Date      Expira-                        Amount or                      (Instr. 5)                   
                               Exer-     tion            Title          Number of                                                   
                               cisable   Date                           Shares                                                      
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

----------------------------------------------------------------------------------------------------------------------------------- 

Explanation of Responses:                                                       

**Intentional misstatements or omissions of facts constitute Federal Criminal   
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).                           

Note:  File three copies of this Form, one of which must be manually signed.    
 If space provided is insufficient, See Instruction 6 for procedure.

                               /s/ David S. Wise              1/3/01
                              -------------------------------  -----------------
                       **Signature of Reporting Person        Date
          On behalf of Sulzer Medica USA
Holding Co.         
Name:  David S. Wise
Title: Secretary    

3
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
Joint Filer Information 
----------------------- 

Name:        Sulzer AG                                                          

IRS Number:  98-0109623                                                         

Address:     Zurcherstrasse 12, P.O. Box 414, CH-8401  Winterthur, Switzerland  

Designated Filer:    Sulzer Medica USA Holding Co.                              

Date of Event Requiring Statement:     12/27/00                                 

Ownership form:  Indirect, Trust Units owned directly by Sulzer Medica USA      
Holding Co.                                                                     

Signature:    /s/ Roman Beran                              1/3/01               
      --------------------------------       -------------------------
On behalf of Sulzer AG                           Date     
Name:  Roman Beran                                        
Title: Deputy Vice President and                          
General Counsel, Head of                    
Legal Department                            

Signature:    /s/ Kurt Haegi                               1/3/01               
     --------------------------------      -------------------------
On behalf of Sulzer AG                           Date     
Name:  Kurt Haegi                                         
Title: Secretary General                                  

Name:     Sulzer Medica Ltd.                                                    

Address:  Zurcherstrasse 12, CH-8401 Winterthur, Switzerland                    

Designated Filer:  Sulzer Medica USA Holding Co.                                

Date of Event Requiring Statement:   12/27/00                                   

Ownership form:  Indirect, Trust Units owned directly by Sulzer Medica USA      
Holding Co.                                                                     

Signature:    /s/ Andre P. Buchel                        1/3/01                 
     --------------------------------      -------------------------
On behalf of SulzerMedica Ltd.                 Date       
Name:  Andre P. Buchel                                    
Title: Chief Executive Officer                            

Signature:    /s/ Vanessa Oelz                           1/3/01                 
     --------------------------------      -------------------------
On behalf of Sulzer Medica Ltd.                Date       
Name:  Vanessa Oelz                                       
Title: Secretary General                                  

                                                                     Page 3 of 3